127 related articles for article (PubMed ID: 38019889)
1. Prevalence of Cervical Cancer and Clinical Management of Women Screened positive using visual inspection with acetic acid and Cervicography in selected public sector health facilities of Manicaland and Midlands provinces of Zimbabwe, 2021.
Tachiwenyika E; Dhodho M; Muchedzi A; Sibanda TP; Mupanguri C; Mukungunugwa S; Mhangara M; Ganje N; Tapera T; Samushonga T; Muzondo M; Dube S; Tafuma T; Chingombe B; Maravanyika A; Nyamundaya T
PLoS One; 2023; 18(11):e0294115. PubMed ID: 38019889
[TBL] [Abstract][Full Text] [Related]
2. Utilization and outcomes of cervical cancer screening services in Harare City, 2012-2016: a secondary data analysis.
Gabaza C; Chonzi P; Chadambuka A; Shambira G; Juru TP; Gombe NT; Nsubuga P; Tshimanga M
BMC Health Serv Res; 2019 Jul; 19(1):454. PubMed ID: 31277655
[TBL] [Abstract][Full Text] [Related]
3. Cervical cancer screening: Safety, acceptability, and feasibility of a single-visit approach in Bulawayo, Zimbabwe.
Fallala MS; Mash R
Afr J Prim Health Care Fam Med; 2015 May; 7(1):. PubMed ID: 26245601
[TBL] [Abstract][Full Text] [Related]
4. Use of Multiplex Polymerase Chain Reaction for Detection of High-Risk Human Papillomavirus Genotypes in Women Attending Routine Cervical Cancer Screening in Harare.
Marembo T; Dube Mandishora R; Borok M
Intervirology; 2019; 62(2):90-95. PubMed ID: 31412350
[TBL] [Abstract][Full Text] [Related]
5. Cervical cancer screening outcomes in Zambia, 2010-19: a cohort study.
Pry JM; Manasyan A; Kapambwe S; Taghavi K; Duran-Frigola M; Mwanahamuntu M; Sikazwe I; Matambo J; Mubita J; Lishimpi K; Malama K; Bolton Moore C
Lancet Glob Health; 2021 Jun; 9(6):e832-e840. PubMed ID: 34019837
[TBL] [Abstract][Full Text] [Related]
6. Cervical cancer management in Zimbabwe (2019-2020).
Zibako P; Tsikai N; Manyame S; Ginindza TG
PLoS One; 2022; 17(9):e0274884. PubMed ID: 36129898
[TBL] [Abstract][Full Text] [Related]
7. Cervical cancer in Zimbabwe: a situation analysis.
Kuguyo O; Matimba A; Tsikai N; Magwali T; Madziyire M; Gidiri M; Dandara C; Nhachi C
Pan Afr Med J; 2017; 27():215. PubMed ID: 28979617
[TBL] [Abstract][Full Text] [Related]
8. Knowledge, attitudes, and practices of cervical Cancer screening among HIV-positive and HIV-negative women participating in human papillomavirus screening in rural Zimbabwe.
Fitzpatrick M; Pathipati MP; McCarty K; Rosenthal A; Katzenstein D; Chirenje ZM; Pinsky B
BMC Womens Health; 2020 Jul; 20(1):153. PubMed ID: 32711530
[TBL] [Abstract][Full Text] [Related]
9. Screening for cervical cancer among HIV-positive and HIV-negative women in Cameroon using simultaneous co-testing with careHPV DNA testing and visual inspection enhanced by digital cervicography: Findings of initial screening and one-year follow-up.
Cholli P; Bradford L; Manga S; Nulah K; Kiyang E; Manjuh F; DeGregorio G; Ogembo RK; Orock E; Liu Y; Wamai RG; Sheldon LK; Gona PN; Sando Z; Welty T; Welty E; Ogembo JG
Gynecol Oncol; 2018 Jan; 148(1):118-125. PubMed ID: 29153541
[TBL] [Abstract][Full Text] [Related]
10. Distribution of cervical abnormalities detected by visual inspection with acetic acid in Swaziland, 2011-2014: A retrospective study.
Ginindza TG; Almonte M; Dlamini X; Sartorius B
Afr J Prim Health Care Fam Med; 2018 Oct; 10(1):e1-e7. PubMed ID: 30456977
[TBL] [Abstract][Full Text] [Related]
11. Cervical cancer screening and treatment, HIV infection, and age: Program implementation in seven regions of Namibia.
Korn AK; Muzingwani L; O'Bryan G; Ensminger A; Boylan AD; Kafidi EL; Kashali M; Ashipala L; Nitschke AM; Dziuban EJ; Forster N; Eckert LO; O'Malley G
PLoS One; 2022; 17(2):e0263920. PubMed ID: 35171941
[TBL] [Abstract][Full Text] [Related]
12. Time taken to link newly identified HIV positive clients to care following a home-base index case HIV testing: Experience from two provinces in Zimbabwe.
Tafuma TA; Mahachi N; Dziwa C; Marowa P; Moga T; Chimbidzikai T; Muchedzi A; Nyagura T; Mpofu M
PLoS One; 2018; 13(8):e0201018. PubMed ID: 30133526
[TBL] [Abstract][Full Text] [Related]
13. Performance of visual inspection with acetic acid and human papillomavirus testing for detection of high-grade cervical lesions in HIV positive and HIV negative Tanzanian women.
Dartell MA; Rasch V; Iftner T; Kahesa C; Mwaiselage JD; Junge J; Gernow A; Ejlersen SF; Munk C; Kjaer SK
Int J Cancer; 2014 Aug; 135(4):896-904. PubMed ID: 24391021
[TBL] [Abstract][Full Text] [Related]
14. Performance of visual Inspection With Acetic Acid for Cervical Cancer Screening as Compared to Human papillomavirus Deoxyribonucleic acid Testing Among Women With HIV in Ethiopia: A Comparative Cross-sectional Study.
Bogale AL; Teklehaymanot T; Kassie GM; Medhin G; Ali JH; Belay NB
Cancer Control; 2022; 29():10732748221114980. PubMed ID: 35829643
[TBL] [Abstract][Full Text] [Related]
15. Utilization of cervical cancer screening services and trends in screening positivity rates in a 'screen-and-treat' program integrated with HIV/AIDS care in Zambia.
Mwanahamuntu MH; Sahasrabuddhe VV; Blevins M; Kapambwe S; Shepherd BE; Chibwesha C; Pfaendler KS; Mkumba G; Vwalika B; Hicks ML; Vermund SH; Stringer JS; Parham GP
PLoS One; 2013; 8(9):e74607. PubMed ID: 24058599
[TBL] [Abstract][Full Text] [Related]
16. Factors affecting cervical cancer screening uptake, visual inspection with acetic acid positivity and its predictors among women attending cervical cancer screening service in Addis Ababa, Ethiopia.
Fentie AM; Tadesse TB; Gebretekle GB
BMC Womens Health; 2020 Jul; 20(1):147. PubMed ID: 32677933
[TBL] [Abstract][Full Text] [Related]
17. Gaps and opportunities for cervical cancer prevention, diagnosis, treatment and care: evidence from midterm review of the Zimbabwe cervical Cancer prevention and control strategy (2016-2020).
Tapera O; Nyakabau AM; Simango N; Guzha BT; Jombo-Nyakuwa S; Takawira E; Mapanga A; Makosa D; Madzima B
BMC Public Health; 2021 Jul; 21(1):1478. PubMed ID: 34320957
[TBL] [Abstract][Full Text] [Related]
18. High-risk human papillomavirus in HIV-infected women undergoing cervical cancer screening in Lilongwe, Malawi: a pilot study.
Reddy D; Njala J; Stocker P; Schooley A; Flores M; Tseng CH; Pfaff C; Jansen P; Mitsuyasu RT; Hoffman RM
Int J STD AIDS; 2015 May; 26(6):379-87. PubMed ID: 24928579
[TBL] [Abstract][Full Text] [Related]
19. Prevalence and Subtype Distribution of High-Risk Human Papillomavirus Among Women Presenting for Cervical Cancer Screening at Karanda Mission Hospital.
Thistle P; Parpia R; Pain D; Lee H; Manasa J; Schnipper LE
JCO Glob Oncol; 2020 Aug; 6():1276-1281. PubMed ID: 32783640
[TBL] [Abstract][Full Text] [Related]
20. The burden of cervical pre-cancer and cancer in HIV positive women in Zambia: a modeling study.
Bateman AC; Katundu K; Mwanahamuntu MH; Kapambwe S; Sahasrabuddhe VV; Hicks ML; Chi BH; Stringer JS; Parham GP; Chibwesha CJ
BMC Cancer; 2015 Jul; 15():541. PubMed ID: 26205980
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
